Literature DB >> 12473811

Bilateral groove sign with penoscrotal elephantiasis.

K Aggarwal1, V K Jain, S Gupta.   

Abstract

Lymphogranuloma venereum (LGV) is a sexually transmitted disease of the lymph channels caused by Chlamydia trachomatis. Esthiomene, a rare late manifestation of LGV, is a primary infection affecting the lymphatics of scrotum, penis, or vulva. The male genitalia are affected less commonly by esthiomene, but we report a male patient who presented with inguinal syndrome, penoscrotal elephantiasis, along with enlargement of femoral lymph nodes.

Entities:  

Mesh:

Year:  2002        PMID: 12473811      PMCID: PMC1758357          DOI: 10.1136/sti.78.6.458

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  2 in total

Review 1.  Lymphogranuloma venereum.

Authors:  L E Becker
Journal:  Int J Dermatol       Date:  1976 Jan-Feb       Impact factor: 2.736

2.  Infiltrative, ulcerative, and fistular lesions of the penis due to lymphogranuloma venereum.

Authors:  V K Hopsu-Havu; C E Sonck
Journal:  Br J Vener Dis       Date:  1973-04
  2 in total
  4 in total

Review 1.  [Penoscrotal elephantiasis: diagnostics and treatment options].

Authors:  V Zugor; R E Horch; A P Labanaris; M Schreiber; G E Schott
Journal:  Urologe A       Date:  2008-04       Impact factor: 0.639

2.  Saxophone penis after unilateral inguinal bubo of lymphogranuloma venereum.

Authors:  Sankha Koley; Rajesh Kumar Mandal
Journal:  Indian J Sex Transm Dis AIDS       Date:  2013-07

3.  Eponymous signs in dermatology.

Authors:  Bhushan Madke; Chitra Nayak
Journal:  Indian Dermatol Online J       Date:  2012-09

4.  Chlamydia trachomatis L2c Infection in a Porcine Model Produced Urogenital Pathology and Failed to Induce Protective Immune Responses Against Re-Infection.

Authors:  Evelien De Clercq; Matthias Van Gils; Katelijn Schautteet; Bert Devriendt; Celien Kiekens; Koen Chiers; Wim Van Den Broeck; Eric Cox; Deborah Dean; Daisy Vanrompay
Journal:  Front Immunol       Date:  2020-10-26       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.